 |
B cell differentiation and the production of tumour-specific antibodies are dynamic processes influenced by changing tumour antigen profiles and microenvironmental signals. By analyzing circulating antibody characteristics and dynamics, we gain insight into the bi-directional engagement between the immune system and tumours, and identify novel blood-based biomarkers that can result in the discovery of novel cancer therapies. Join us for this this insightful webinar to learn how antibody profiling has been used to successfully identify novel diagnostic, prognostic, therapeutic, and predictive biomarkers in melanoma, prostate cancer, breast cancer, ovarian cancer, and rare cancers, yielding promising results. See how simultaneously assaying a significant proportion of the systemic tumour antigen-specific antibody repertoire, a unique snapshot of the tumour can be obtained which circumvents the influence of inter- and intra- tumour heterogeneity that affect tissue-based techniques. Don’t miss out on this opportunity to discover the latest advances in cancer research! |
